ZA200609635B - Mitochondrially targeted antioxidants in the treatment of liver diseases and epithelial cancers - Google Patents

Mitochondrially targeted antioxidants in the treatment of liver diseases and epithelial cancers

Info

Publication number
ZA200609635B
ZA200609635B ZA200609635A ZA200609635A ZA200609635B ZA 200609635 B ZA200609635 B ZA 200609635B ZA 200609635 A ZA200609635 A ZA 200609635A ZA 200609635 A ZA200609635 A ZA 200609635A ZA 200609635 B ZA200609635 B ZA 200609635B
Authority
ZA
South Africa
Prior art keywords
treatment
liver diseases
epithelial cancers
mitochondrially targeted
targeted antioxidants
Prior art date
Application number
ZA200609635A
Other languages
English (en)
Inventor
Froehlich Eleonore
Kvietikova Ivica
Zatloukal Kurt
Schatz Gottfried
Denk Helmut
Stumptner Cornelia
Buck Charles
Original Assignee
Oridis Biomed Forschungs Und E
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oridis Biomed Forschungs Und E filed Critical Oridis Biomed Forschungs Und E
Publication of ZA200609635B publication Critical patent/ZA200609635B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ZA200609635A 2004-07-13 2006-11-20 Mitochondrially targeted antioxidants in the treatment of liver diseases and epithelial cancers ZA200609635B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04103318 2004-07-13

Publications (1)

Publication Number Publication Date
ZA200609635B true ZA200609635B (en) 2008-08-27

Family

ID=34929318

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200609635A ZA200609635B (en) 2004-07-13 2006-11-20 Mitochondrially targeted antioxidants in the treatment of liver diseases and epithelial cancers

Country Status (11)

Country Link
US (1) US20070225255A1 (ja)
EP (1) EP1765413A2 (ja)
JP (1) JP2008506667A (ja)
CN (1) CN1997403A (ja)
AU (1) AU2005261654A1 (ja)
CA (1) CA2573456A1 (ja)
IL (1) IL179738A0 (ja)
RU (1) RU2007105138A (ja)
SG (1) SG156613A1 (ja)
WO (1) WO2006005759A2 (ja)
ZA (1) ZA200609635B (ja)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170102377A (ko) 2004-01-22 2017-09-08 유니버시티 오브 마이애미 국소용 코-엔자임 큐10 제형 및 그의 사용 방법
US20080032940A1 (en) * 2006-08-07 2008-02-07 Balaraman Kalyanaraman Methods for reducing anthracycline-induced toxicity
WO2008048134A1 (fr) 2006-10-20 2008-04-24 Limited Liability Company 'mitotechnology' Compositions pharmaceutiques pour la prévention et le traitement de pathologies oculaires
WO2008048135A1 (fr) 2006-10-20 2008-04-24 Limited Liability Company 'mitotechnology' Composition destinée à la régénération, la stimulation de la croissance et l'adaptation de plantes à tous types de facteurs de stress
WO2008094061A1 (fr) * 2007-01-29 2008-08-07 Limited Liability Company 'mitotechnology' Compositions pharmaceutiques et cosmétiques servant à accélérer le processus de cicatrisation de plaies et autres lésions superficielles
US8349902B2 (en) * 2007-01-29 2013-01-08 Mitotech Sa Pharmaceutical compositions useful for preventing and treating oncological diseases
EA201000142A1 (ru) 2007-04-11 2010-04-30 Общество С Ограниченной Ответственностью "Митотехнология" Композиция, замедляющая старение и увеличивающая продолжительность жизни организма, и ее применение
US8518915B2 (en) 2007-06-29 2013-08-27 Mitotech Sa Use of mitochondrially-addressed compounds for preventing and treating cardiovascular diseases
CN101848918A (zh) * 2007-09-07 2010-09-29 吉奇亚公司 线粒体组合物及其用途
US8388936B2 (en) * 2008-02-22 2013-03-05 Mcw Research Foundation, Inc. In vivo mitochondrial labeling using positively-charged nitroxide enhanced and gadolinium chelate enhanced magnetic resonance imaging
US8388931B2 (en) * 2008-02-29 2013-03-05 Marcos Lopez 99m Tc-labeled triphenylphosphonium derivative contrasting agents and molecular probes for early detection and imaging of breast tumors
WO2009126764A1 (en) 2008-04-11 2009-10-15 Cytotech Labs, Llc Methods and use of inducing apoptosis in cancer cells
WO2010056145A1 (ru) 2008-11-12 2010-05-20 Общество С Ограниченной Ответственностью "Митотехнология" Способ умеренного повышения протонной проводимости биологических мембран при помощи митохондриально- адресованных делокализованных катионов
BRPI1014978A2 (pt) * 2009-04-17 2019-07-02 Colby Pharmaceutical Company método de tratamento do câncer e composição farmacêutica.
WO2010132502A2 (en) 2009-05-11 2010-11-18 Cytotech Labs, Llc Methods for treatment of metabolic disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
UA104320C2 (ru) 2009-06-10 2014-01-27 Общество С Ограниченной Ответственностью "Мимотех" Фармацевтическая композиция на основе митохондриально-адресованного антиоксиданта для применения в медицинской и ветеринарной офтальмологии
KR20120125980A (ko) 2009-11-13 2012-11-19 리미티드 라이어빌러티 컴퍼니 미토테크 미토콘드리아 표적화된 항산화제에 기초한 약학적 물질
AU2012240222B2 (en) 2011-04-04 2017-04-27 Berg Llc Methods of treating central nervous system tumors
JP6448366B2 (ja) 2011-06-03 2019-01-09 ミトテック ソシエテ アノニム ミトコンドリアを標的とする抗酸化剤の経口製剤ならびにそれらの調製および使用
JP2014527969A (ja) * 2011-09-19 2014-10-23 ジェンシア コーポレイション 改変クレアチン化合物
US10933032B2 (en) 2013-04-08 2021-03-02 Berg Llc Methods for the treatment of cancer using coenzyme Q10 combination therapies
PT2989110T (pt) * 2013-04-24 2018-11-15 Jira­ Neuzil Derivados de tamoxifeno para o tratamento de doenças neoplásicas, especialmente com nível elevado de proteína her2
EP3730131A1 (en) 2013-09-04 2020-10-28 Berg LLC Methods of treatment of cancer by continuous infusion of coenzyme q10
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
KR101773404B1 (ko) 2015-08-25 2017-08-31 (주) 씨유스킨 자외선에 의한 피부 손상의 예방 또는 개선을 위한 화장료 조성물
CN107510848A (zh) * 2016-06-15 2017-12-26 常州莱道斯生物医药科技有限公司 线粒体靶向制剂MitoPBN在防治糖尿病中的应用
CN108201543A (zh) * 2016-12-19 2018-06-26 北京福纳康生物技术有限公司 水溶性富勒烯结构在制备治疗脂肪肝的药物中的应用
CN115381804A (zh) * 2022-08-10 2022-11-25 华南师大(清远)科技创新研究院有限公司 癸基泛醌在制备治疗肝纤维化药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9722361D0 (en) * 1997-10-24 1997-12-17 Pharma Nord Uk Ltd Pharmaceutical formulation for treating liver disorders
US6331532B1 (en) * 1998-11-25 2001-12-18 University Of Otago Mitochondrially targeted antioxidants
WO2005019233A1 (en) * 2003-08-22 2005-03-03 Antipodean Pharmaceuticals, Inc. Mitoquinone derivatives used as mitochondrially targeted antioxidants
CA2354743A1 (en) * 2001-08-07 2003-02-07 University Of Otago Mitochondrially targeted antioxidants
NZ513547A (en) * 2001-08-13 2002-09-27 Antipodean Biotechnology Ltd Synthesis of triphenylphosphonium quinols (e.g. mitoquinol) and/or quinones (e.g. mitoquinone)

Also Published As

Publication number Publication date
IL179738A0 (en) 2007-05-15
AU2005261654A1 (en) 2006-01-19
CN1997403A (zh) 2007-07-11
EP1765413A2 (en) 2007-03-28
RU2007105138A (ru) 2008-08-20
CA2573456A1 (en) 2006-01-19
WO2006005759A3 (en) 2006-05-11
JP2008506667A (ja) 2008-03-06
US20070225255A1 (en) 2007-09-27
WO2006005759A2 (en) 2006-01-19
SG156613A1 (en) 2009-11-26

Similar Documents

Publication Publication Date Title
IL179738A0 (en) Mitochondrially targeted antioxidants in the treatment of liver diseases and epithelial cancers
EP1968607A4 (en) TREATMENT OF CANCER AND OTHER DISEASES
IL241756A0 (en) Preparations and methods for the treatment of diseases of safty tumors
HK1077583A1 (en) Cudr as biomarker for cancer progression and therapeutic response
EP1749095A4 (en) NEW THERAPEUTIC TARGETS IN CANCER
EP1781689A4 (en) CONJUGATES AND THEIR THERAPEUTIC APPLICATIONS
IL227841A0 (en) Dihydropyridinones for the treatment of cancer
IL184047A0 (en) Methods and compositions for treating amyloid-related diseases
IL181608A0 (en) Cancer combination therapy comprising azd2171 and imatinib
EP1737482A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES
IL190332A0 (en) Human antibodies against il13 and therapeutic uses
IL182498A0 (en) Therapeutic furopyrimidines and thienopyrimidines
IL178012A0 (en) Diphenyl-indol-2-on compounds and their use in the treatment of cancer
IL182643A0 (en) Novel composition and methods for the treatment of immune related diseases
IL191072A0 (en) Therapeutic compositions and methods
IL180278A0 (en) Fused pyrimidones useful in the treatment and the prevention of cancer
EP1812596A4 (en) TREATMENT OF CANCER AND COMPOSITIONS
GB0418328D0 (en) Cancer methods and medicaments
IL182652A0 (en) Nitrobenzindoles and their use in cancer therapy
ZA200600025B (en) Methods and compositions for interferon therapy
EP2012798A4 (en) USE OF INOSITOL-TRIPYROPHOSPHATE IN THE TREATMENT OF TUMORS AND DISEASES
EP1805210A4 (en) NOVEL PEPTIDES AND METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASE
EP1871166A4 (en) VACCINES AGAINST CANCER AND THERAPEUTIC METHODS
EP1778873A4 (en) NEW THERAPEUTIC TARGETS AGAINST CANCER
EP1755669A4 (en) METHODS AND COMPOSITIONS FOR SPECIFIC TARGETING OF HEPATOCELLULAR CARCINOMA CELLS IN MAN